Neo Ivy Capital Management Haemonetics Corp Transaction History

Neo Ivy Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$81.24 - $97.37 $3.31 Million - $3.97 Million	40,780 New	40,780 $3.37 Million
Q4 2021 Feb 15, 2022	SELL	$49.55 - $74.59 $24,130 - $36,325	-487 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$57.6 - $70.59 $28,051 - $34,377	487 New	487 $44,000
Q2 2020 Aug 17, 2020	SELL	$84.96 - $118.91 $41,375 - $57,909	-487 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$84.96 - $118.91 $169 - $237	2 Added 0.41%	487 $44,000
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $36,054 - $59,082	485 New	485 $48,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.